×
About 2,068 results

ALLMedicine™ Antinuclear Antibody Center

Research & Reviews  633 results

Clinical and Autoantibody Associations in Antinuclear Antibody-Positive Systemic Sclero...
https://doi.org/10.1097/RHU.0000000000001881
Journal of Clinical Rheumatology : Practical Reports on R... Kruzer K, Goncalves Marangoni R et. al.

Jun 30th, 2022 - Clinical and Autoantibody Associations in Antinuclear Antibody-Positive Systemic Sclerosis Lacking Prototypic Autoantibodies.|2022|Kruzer K,Goncalves Marangoni R,Heckler I,Elhage A,Varga J,|

Tumor Necrosis Factor α Inhibitor–Induced Lupuslike Syndrome in a Patient Prescribed Certolizumab Pegol
https://www.mdedge.com/dermatology/article/255803/dermatopathology/tumor-necrosis-factor-inhibitor-induced-lupuslike
David Walton Crasto Jr, DO, Loren Touma, DO et. al.

Jun 28th, 2022 - To the Editor: Tumor necrosis factor α (TNF-α) inhibitor–induced lupuslike syndrome (TAILS) is a newly described entity that refers to the onset of subacute cutaneous lupus erythematosus (SCLE) during drug therapy with TNF-α antagonists. The condi.

Clinical significance of HEp-2 cell cytoplasmic patterns in anti-neutrophil cytoplasmic...
https://doi.org/10.1097/MD.0000000000029498
Medicine Zhang N, Ji C et. al.

Jun 28th, 2022 - The study was to investigate the clinical characteristics and significance of antinuclear antibody (ANA) cytoplasmic patterns in ANCA-associated vasculitis (AAV) from Southwest China.A retrospective study including 232 AAV patients from Peoples Ho...

Purple-brown coalescing macules on the mandibular area of the face.
https://doi.org/10.1111/ced.15257
Clinical and Experimental Dermatology; Baglama ŠŠ, Barać TO et. al.

Jun 23rd, 2022 - This patient presented with a 1-year history of violaceous-brown, coalescing reticulated macules on his face, with no similar lesions in other body areas. Laboratory findings were normal and antinuclear antibody test was negative. Histopathologica...

A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
https://clinicaltrials.gov/ct2/show/NCT04088409

Jun 23rd, 2022 - The reason for this study is to see if the study drug baricitinib given orally is safe and effective in participants with active juvenile idiopathic arthritis (JIA)-associated uveitis or chronic anterior antinuclear antibody-positive uveitis from ...

see more →

Drugs  9 results see all →

Clinicaltrials.gov  14 results

A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
https://clinicaltrials.gov/ct2/show/NCT04088409

Jun 23rd, 2022 - The reason for this study is to see if the study drug baricitinib given orally is safe and effective in participants with active juvenile idiopathic arthritis (JIA)-associated uveitis or chronic anterior antinuclear antibody-positive uveitis from ...

Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy
https://clinicaltrials.gov/ct2/show/NCT02317627

May 26th, 2022 - Study KD025-206 was a phase 2, open-label, dose-finding, safety, tolerability, activity, and PK study of KD025 in subjects with psoriasis who had failed at least 1 line of systemic therapy or phototherapy. Subjects received KD025 PO for 12 weeks. ...

Eltrombopag Combined With Low-dose Rituximab in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
https://clinicaltrials.gov/ct2/show/NCT04915482

May 11th, 2022 - This is a prospective, open-label, nonrandomized, multicenter clinical trial aiming at comparing the efficacy and safety of combined use of eltrombopag with low-dose rituximab vs. the best available therapy(BAT)in adult immune thrombocytopenia (...

Effects of Silica and Asbestos Fibres on the Efferocytosis Capacities of Macrophages
https://clinicaltrials.gov/ct2/show/NCT04473742

Jan 4th, 2022 - Patients with a proven history or current exposure will have 4 EDTA tubes drawn, approximately 24mL of fresh whole blood for efferocytosis assessment and : 2 x 6mL serum tubes for the assessment of Antinuclear Antibody (ANA) positivity, serum high...

Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
https://clinicaltrials.gov/ct2/show/NCT04993885

Aug 6th, 2021 - This prospective, open-label, single-center, one-arm clinical trial aims at evaluating the efficacy and safety of avatrombopag in Chinese adult ITP patients with autoantibodies fail (due to intolerance or resistance) to eltrombopag or herombopag t...

see more →

News  167 results

Tumor Necrosis Factor α Inhibitor–Induced Lupuslike Syndrome in a Patient Prescribed Certolizumab Pegol
https://www.mdedge.com/dermatology/article/255803/dermatopathology/tumor-necrosis-factor-inhibitor-induced-lupuslike
David Walton Crasto Jr, DO, Loren Touma, DO et. al.

Jun 28th, 2022 - To the Editor: Tumor necrosis factor α (TNF-α) inhibitor–induced lupuslike syndrome (TAILS) is a newly described entity that refers to the onset of subacute cutaneous lupus erythematosus (SCLE) during drug therapy with TNF-α antagonists. The condi.

New Blood Tests Approved for Lupus, Systemic Sclerosis Diagnoses
https://www.medscape.com/viewarticle/975837

Jun 17th, 2022 - The Food and Drug Administration has approved a new diagnostic blood test to detect monospecific Ribosomal P antibodies to support a diagnosis of systemic lupus erythematosus (SLE), particularly for people who are antinuclear antibody-negative, ac...

Pemphigus Vulgaris Aggravated: Rifampicin Found at the Scene of the Crime
https://www.mdedge.com/dermatology/article/254976/autoimmune-diseases/pemphigus-vulgaris-aggravated-rifampicin-found-scene
Lifang Hu, MD, Yan Sun, MD et. al.

May 25th, 2022 - Case Report A 60-year-old man presented with eroded areas in the mouth and blistering eruptions on the scalp, face, trunk, arms, and legs. He initially presented to an outside hospital 4 years prior and was treated with oral prednisone 50 mg daily.

Mixed Results for Oral Lupus Drug in Phase II
https://www.medpagetoday.com/rheumatology/lupus/97690

Mar 16th, 2022 - What could be the first oral medication specific for systemic lupus erythematosus (SLE) was more effective than placebo in a randomized phase II trial, though the results were something less than a home run. With 288 patients assigned to three dos...

Painful swelling of fingers and toe
https://www.mdedge.com/psoriatic-arthritis-challenge-center/article/252591/psoriatic-arthritis/painful-swelling-fingers-and

Mar 9th, 2022 - Although psoriatic arthritis is not the only disease associated with dactylitis — other culprits are sarcoidosis, septic arthritis, tuberculosis, and gout — dactylitis is one of the characteristic symptoms of psoriatic arthritis. Dactylitis is see.

see more →

Patient Education  4 results see all →